Item
Gender
text
C0079399 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
C0005910 (UMLS CUI [1,3])
C2229760 (UMLS CUI [1,4])
Allergic asthma
Item
Asthma symptoms are mainly
text
C0155877 (UMLS CUI [1,1])
C0440307 (UMLS CUI [1,2])
C0440328 (UMLS CUI [1,3])
C0861154 (UMLS CUI [1,4])
rast positive
Item
patients with a positive rast (>cap2) result for grass pollen (and/or rye pollen) specific ige at screening (visit 1 (v1) or within the previous 12 months.
boolean
C0855586 (UMLS CUI [1])
FEV1
Item
FEV1
integer
C0748133 (UMLS CUI [1])
pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1,1])
C3831118 (UMLS CUI [1,2])
C0700589 (UMLS CUI [1,3])
C0006147 (UMLS CUI [1,4])
comorbidity
Item
any coexisting major illness or organ failure
boolean
C0009488 (UMLS CUI [1,1])
C0260472 (UMLS CUI [1,2])
History of allergies
Item
History of allergy/hypersensitivity (including medication allergy) that is deemed relevant to the trial by the investigator. Relevance in this context refers to any increased risk of hypersensitivity reaction to trial medication. (Specific concerns currently identified with respect to the use of inhaled glutathione in allergic patients per se are not existing)
boolean
C0489531 (UMLS CUI [1,1])
C3662483 (UMLS CUI [1,2])
C0004034 (UMLS CUI [1,3])
C0339808 (UMLS CUI [1,4])
Drug-induced anaphylactoid reaction
Item
2. patients with a history of food or drug related severe anaphylactoid or anaphylactic reaction(s).
boolean
C0344178 (UMLS CUI [1,1])
C0685898 (UMLS CUI [1,2])
Allergy
Item
Hypersensitivity
text
C0020517 (UMLS CUI [1])
Allergy
Item
Hypersensitivity
text
C0020517 (UMLS CUI [1,1])
C0013182 (UMLS CUI [1,2])
C0038636 (UMLS CUI [1,3])
C0019602 (UMLS CUI [1,4])
C0032600 (UMLS CUI [1,5])
C0966225 (UMLS CUI [1,6])
C0003250 (UMLS CUI [1,7])
C1328603 (UMLS CUI [1,8])
C0021083 (UMLS CUI [1,9])
Allergy
Item
Hypersensitivity
text
C0020517 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0013182 (UMLS CUI [1,3])